Recent Developments in Fertility Treatment and Management Driving Global Market Growth

Global fertility tourism market is anticipated to grow at a CAGR of 12.6% during the forecast period (2024-2031). The increasing adoption of infertility treatment options including In-Vitro Fertilization (IVF), surrogacy, cryopreservation, and fertility medications has created a huge demand for fertility tourism. IVF is a common ART for fertilizing eggs outside the body. Intracytoplasmic Sperm Injection (ICSI) treats male infertility. Egg and Sperm Donation, Preimplantation Genetic Diagnosis (PGD), surrogacy, cryopreservation, and fertility medications are used to treat ovulation and increase sperm production. The ongoing developments in infertility treatment technologies are a key factor driving the global fertility tourism market. 

Browse the full report description of “Fertility Tourism Market Size, Share & Trends Analysis Report By Service (In Vitro Fertilization (IVF) Services, Egg Donation Services, Sperm Donation Services, Surrogacy Services, and Others), by Age (Below 28 Years, 28-34 Years, and Above 35 Years), and by End-User (Female, and Male) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/fertility-tourism-market

Recent Market Developments

• In March 2024, TMRW Life Sciences launched CryoLink, a workstation that enables digital management of fertility clinics' frozen specimen inventory. This system allows clinics to access TMRW's Digital Specimen Management system with or without automated storage platforms. The CryoLink system is an intermediate step for clinics to improve critical storage processes without significant investments in time, resources, and facilities.

• In August 2023, Virtus Health launched IVF(SG), a new private fertility clinic in Singapore, aiming to address challenges in the public and private fertility treatment segment. IVF(SG) offers private IVF services at public hospital rates, using a simplified, science-driven treatment model and a team-based approach. It joins Virtus Fertility Centre Singapore as the second clinic under Virtus Health, providing affordable, effective, and science-based care.

• In September 2023, Merck launched a fertility benefit program in eight European, Asia, and Latin American markets, providing financial support for fertility treatments for employees and their partners, similar to similar benefits offered to employees in the US, Canada, and Japan.

Market Coverage

• The market number available for – 2023-2031

• Base year- 2023

• Forecast period- 2024-2031

• Segment Covered- 

o By Service

o By Age Group

o By End-User

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape - Apollo Specialty Hospitals Pvt. Ltd., Bourn Hall Ltd., Manchester Fertility Services Ltd, San Diego Fertility Center, and The Fertility Partners Inc. among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Fertility Tourism Market Report Segment

By Service

• In Vitro Fertilization (IVF) Services
• Egg Donation Services
• Sperm Donation Services
• Surrogacy Services
• Others (Fertility Medications and Hormonal Treatments)

By Age Group

• Below 28 Years
• 28-34 Years
• Above 35 Years

By End-User

• Female
• Male

Global Fertility Tourism Market Report Segment by Region

North America

• United States

• Canada 

Europe

• UK

• Germany

• Italy

• Spain

• France

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/fertility-tourism-market